Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Search Results

Refine Your Search

By Sector

Sort by: Date|Relevance

Buzz on the Bullboards: Investment Opportunities on the Rise

(Image via Datametrex AI Ltd.) A busy week for the markets means a busy week for the Stockhouse Bullboards. From sudden investment opportunities to new sector mainstays, we saw a little bit of everything over the last seven days. First up, here&CloseCurlyQuo...

Does this Device Solve the Issue of Electromagnetic Radiation?

There is a large health issue that few know about and does not see much press, but it is there for everyone to see buried in the fine print when you buy most cell phones. I am talking about electromagnetic radiation (EMR) that is emitted with electronic devices, such as...

Biotech to Test Stem Cell Product in COVID-19-Caused Acute Respiratory Distress

A description of Mesoblast's multi-site clinical trial and possible implication for the therapeutic are provided in an H.C. Wainwright & Co. report.

Adaptimmune Shares Triple as SPEAR T-cell Platform Delivers Initial Responses ...

Adaptimmune Shares Triple as SPEAR T-cell Platform Delivers Initial Responses in Four Solid Tumor Indications Shares of Adaptimmune Therapeutics more than tripled in value after the company reported that its SPEAR T-cell platform delivered positive initial responses in...

Big-Time Communications Play = A Profitable Small-Cap Opportunity

(Click image to play video) The importance of clear, reliable communications cannot be understated. From smartphones to emergency broadband radio transceivers to advanced military / civilian satellite systems…every aspect of our everyday lives is dependent on st...

Syros Pharma Teams Up with Global Blood Therapeutics to Fight Sickle Cell Disease

Syros Pharmaceuticals' shares rose 20% today after the firm reported that it entered into a collaboration agreement with Global Blood Therapeutics for development of therapies for sickle cell disease and beta thalassemia that could result in payments to Syros as high as $315 m...

Mackie Research: Small Cap a World Leader in Health and Safety Wearables

Note: This article is not research and any companies mentioned are not rated. TraceSafe Technologies Inc . is a wholly owned subsidiary of Blockchain Holdings Ltd. (BCX:CSE) , and owns 100% of the rights and interests in the real-time location tracking technology ...

FDA Accepts NDA for Global Blood Therapeutics' Sickle Cell Drug; Shares Up 14%

Shares of Global Blood Therapeutics are trading more than 14% higher after the FDA accepted its New Drug Application filing for Voxelotor, a drug used in the treatment of sickle cell disease. Earlier today clinical-stage biopharmaceutical firm Global Blood Therapeuti...

Visionstate continues to launch WANDA in new markets

TMH: Visionstate is a growth-oriented company investing primarily in the Internet of Things, big data and analytics, and sustainability. The Edmonton-based tech firm’s proprietary smart technology now extends to a range of public facilities across a...

Trillion-dollar US infrastructure plan will draw in plenty of metal

Donald Trump appears to have torn a page from Ahead of the Herd’s manual for recharging the US economy. In an earlier article we said what the global economy really needs, in this low-growth, spending-stalled environment brought about by the pandemic, is...
1 2 3 4 5 6 7 8 9 10 ...